Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,312 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07711171RecruitingPhase 4
Canagliflozin for type 2 diabetes with mild memory problems
This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.
Shanghai, Shanghai MunicipalityAges 40–75 - NCT07713550Recruiting
Genetic profiling to guide treatment for advanced solid tumors
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
AnderlechtAges 18 years+ - NCT06641544RecruitingPhase 4
Testing different drug combos for HER2-positive breast cancer
This trial tests different combinations of the drug Inetetamab as a first treatment for breast cancer that has spread and is HER2-positive. It aims to find which combo works best and is safe for newly diagnosed metastatic patients.
Shanwei, GuangdongAges 18–70 - NCT06641206Recruiting
Dexmedetomidine injection for chronic knee pain
This trial tests whether a single injection of dexmedetomidine into the knee joint can reduce chronic knee pain. It is for people who are not scheduled for knee surgery and have no serious health problems.
Tanta, El GharbyiaAges 40–75 - NCT04981145RecruitingPhase 4
Iguratimod for Sjögren’s syndrome symptoms and safety
This trial studies whether iguratimod improves symptoms in people with primary Sjögren’s syndrome, and checks how safe it is. It focuses on people with confirmed disease markers (anti-SSA/Ro-60) and ongoing dry eyes and dry mouth.
Hangzhou, ZhejiangAges 18–70 - NCT05584566Recruiting
Bone growth treatment before dental implants: two materials compared
This study compares two bone-building products used to repair a missing “bone wall” in the jaw so dental implants can be placed. You may be able to help find which material works better for guided bone regeneration and implant readiness.
JerusalemAges 18 years+ - NCT06302985Recruiting
Inhaled dye for lung malformations in children
This trial tests a new way to use a dye called ICG (indocyanine green) that is inhaled like a mist. It may help doctors see and treat congenital lung malformations in children more clearly.
Wuhan, HubeiAges 3 months–14 years - NCT02222844Recruiting
MRI checks for treatment planning in sigmoid colon cancer
This study uses MRI scans to better plan “curative” treatment (aimed at cure) for sigmoid colon cancer before surgery. It is for people who may still be deciding on the radical (major, curative) treatment plan and who can safely have an MRI.
Huntingdon, CambridgeshireAges 16 years+ - NCT07700966Recruiting
Long-term safety registry for EB treatment
This study follows patients who have already received a gene therapy treatment called prademagene zamikeracel for a severe skin condition called recessive dystrophic epidermolysis bullosa (RDEB). The goal is to track long-term safety and health outcomes after treatment.
Palo Alto, CaliforniaAges Any age - NCT07700238RecruitingPhase 3
Romiplostim plus steroids vs steroids alone for newly diagnosed ITP
This trial tests if adding romiplostim (a drug that helps make platelets) to standard steroid treatment works better than steroids alone for adults who have not been treated for ITP before. It is for people with low platelet counts and may help reduce bleeding.
Long Beach, CaliforniaAges 18–100 - NCT07700979RecruitingPhase 3
Testing a new drug combo for stomach cancer
This trial tests a new immunotherapy drug called cadonilimab combined with chemotherapy for people with advanced stomach cancer that hasn't been treated yet. It compares this combination to chemotherapy with or without another immunotherapy drug, nivolumab.
Phoenix, ArizonaAges 18 years+ - NCT03716843Recruiting
Testing a pressure-sensing brace for teen scoliosis care
This trial tests a dynamic pressure monitoring system that tracks how a brace is applying pressure during treatment for adolescent idiopathic scoliosis. It may help doctors better adjust brace therapy to improve outcomes and comfort.
Tsim Sha Tsui, KolwoonAges 10–15 - NCT07703488Recruiting
Dydrogesterone for abnormal uterine bleeding in teens
This trial tests if dydrogesterone, a hormone pill, can safely help teenagers with heavy or irregular periods. If you or your child have had unusual bleeding that isn't caused by pregnancy or other medical issues, this study may provide treatment options.
Guangzhou, GuangongAges 10–19 - NCT07706127Recruiting
Texting support for Latina breast cancer patients on hormone therapy
This study tests if a text message program can help Latina breast cancer patients remember to take their hormone therapy pills. It also looks at how non-medical challenges (like money or housing issues) affect medication taking.
San Antonio, TexasAges 18 years+ - NCT07703891Recruiting
Testing B-OK Bottles for HIV Medication Understanding in South Africa
This study tests a special 'B-OK' bottle designed to help people understand their HIV medication better. If you live in Gauteng and can come to the study offices for one visit, you might help find better ways to support HIV treatment with simple tools.
Johannesburg, GautengAges 18 years+ - NCT07700498Recruiting
Combined cataract and glaucoma surgery for new patients
This trial tests a single surgery to treat both glaucoma and cataracts at the same time. It is for people who have not had any prior glaucoma treatment and need cataract surgery.
Ningxia, NingxiaAges 40–85 - NCT07704476Recruiting
Protein supplement after breast cancer treatment
This study tests whether taking a protein supplement plus resistance training can help improve muscle and body composition after breast cancer treatment. It could be for you if you have finished active breast cancer treatment and have been doing strength training for at least 3 months.
Pittsburgh, PennsylvaniaAges 20–89 - NCT07705919RecruitingPhase 1/Phase 2
MRI scans to monitor borderline resectable pancreatic cancer treatment
This study uses MRI scans to see how well chemotherapy and radiation work in people with borderline resectable pancreatic cancer – a type where surgery might be possible but is risky. The goal is to find the best way to measure tumor response so doctors can make better treatment decisions.
Columbus, OhioAges 18 years+ - NCT07698314Recruiting
Exercise study for women after breast cancer treatment
This study looks at how a supervised exercise program affects muscle-related substances (myokines) in women who have finished breast cancer treatment. It may help understand how exercise can support recovery.
Pittsburgh, PennsylvaniaAges 20–89 - NCT07700537Recruiting
Brain stimulation for speech recovery after recent stroke
This study tests a gentle brain stimulation treatment called tDCS to help people recover speech after a recent stroke. If you had a first-time stroke on the left side of your brain within the past 3 months and now have trouble speaking (aphasia), this treatment may help your brain relearn language.
Hefei, AnhuiAges 18–80 - NCT07704632Recruiting
Focused ultrasound helmet for severe OCD
This study tests whether a special helmet that uses focused ultrasound can safely change brain activity in adults with severe OCD that hasn't improved with other treatments. It may offer a new option for people who have not found relief from medications or therapy.
Toronto, OntarioAges 18–85 - NCT07701616Recruiting
Digital mindfulness therapy for obsessive-compulsive disorder
This study tests a smartphone-based mindfulness program to help people with obsessive-compulsive disorder (OCD) reduce their symptoms. If you have OCD and are between 12 and 65 years old, you may be able to join.
Changsha, HunanAges 12–65 - NCT07697924Recruiting
Cord blood therapy for thin uterine lining
This study tests if a special treatment made from cord blood can help women with a thin uterine lining (the inner layer of the womb) or Asherman syndrome (scar tissue). The goal is to see if it can improve the lining so it's healthier for pregnancy.
ValenciaAges 18–48 - NCT01993498Recruiting
Study side effects of cancer treatment in localized breast or lung cancer
This study looks at long-term side effects from standard cancer treatments and how they affect daily life and resources. It may help improve care for people with breast or lung cancer that has not spread.
VillejuifAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,312 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.